Immunocompetent murine model of cancer cachexia for head and neck squamous cell carcinoma

Head and Neck

Volumn 30, Issue 3, 2008, Pages 320-326

  Cannon, Trinitia ^a,b   Shores, Carol ^a,b   Yin, Xiaoying ^a,b   Dahlman, Jason ^c,d,e   Guttridge, Denis ^c,d,e   Lai, Victor ^a   George, Jonathan ^a   Buzkova, Petra ^b   Couch, Marion ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

Cancer cachexia; Head and neck cancer; Muscle atrophy

Indexed keywords

INTERLEUKIN 1BETA; MUSCLE RING FINGER 1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; BODY WEIGHT; C3H MOUSE; CACHEXIA; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HEAD AND NECK CARCINOMA; HINDLIMB; MOUSE; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR CELL; WEIGHT REDUCTION;

ANIMALS; CACHEXIA; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; HEAD AND NECK NEOPLASMS; HINDLIMB; IMMUNOCOMPETENCE; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; MICE; MICE, INBRED C3H; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NEOPLASM TRANSPLANTATION; PEPTIDES; UBIQUITIN-PROTEIN LIGASES;

EID: 41649122151     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20698     Document Type: Article

References (21)

1. Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer 2002;2:862-871.
2. O'Gorman P, McMillan DC, McArdle CS. Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer 2000;37:36-40.
3. Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980;69:491-497.
4. Inagaki J, Rodriguez V, Bodey GP. Proceedings: causes of death in cancer patients. Cancer 1974;33:568-573.
5. Tisdale MJ. Clinical anticachexia treatments. Nutr Clin Pract 2006;21:168-174.
6. Couch M, Lai V, Cannon T, et al. Cancer cachexia syndrome in head and neck cancer patients: Part 1. Diagnosis, impact on quality of life and survival, and treatment. Head Neck 2007;29:401-411.
7. George J, Cannon T, Lai V, et al. Cancer cachexia syndrome in head and neck cancer patients: Part 2. Pathophysiology. Head Neck 2007;29:497-507.
8. Bing C, Bao Y, Jenkins J, et al. Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci U S A 2004;101:2500-2505.
9. Russell ST, Tisdale MJ. Effect of eicosapentaenoic acid (EPA) on expression of a lipid mobilizing factor in adipose tissue in cancer cachexia. Prostaglandins Leukot Essent Fatty Acids 2005;72:409-414.
10. Argiles JM, Busquets S, Lopez-Soriano FJ. Cytokines in the pathogenesis of cancer cachexia. Curr Opin Clin Nutr Metab Care 2003;6:401-406.
11. Strassmann G, Masui Y, Chizzonite R, Fong M. Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor. J Immunol 1993;150:2341-2345.
12. Acharyya S, Ladner K, Nelsen L, et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 2004;114:370-378.
13. Tanaka Y, Eda H, Tanaka T, et al. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res 1990;50:2290-2295.
14. O'Malley BW Jr, Cope KA, Johnson CS, Schwartz MR. A new immunocompetent murine model for oral cancer. Arch Otolaryngol Head Neck Surg 1997;123:20-24.
15. Couch M, Saunders JK, O'Malley BW Jr, Pardoll D, Jaffee E. Genetically engineered tumor cell vaccine in a head and neck cancer model. Laryngoscope 2003;113:552-556.
16. Iida-Klein A, Lu SS, Yokohama K, et al. Precision, accuracy, and reproducibility of dual X-ray absorptiometry measurements in mice in vivo. J Clin Densitom 2003;6:25-33.
17. Acharyya S, Butchbach ME, Sahenk Z, et al. Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell 2005;8:421-432.
18. Mulligan HD, Mahony SM, Ross JA, Tisdale MJ. Weight loss in a murine cachexia model is not associated with the cytokines tumour necrosis factor-α or interleukin-6. Cancer Lett 1992;65:239-243.
19. Ozaki K, Yoshida S, Ishibashi N, Kamei H, Muraoka T, Shirouzu K. Effect of tumor weight and tube feeding on TNF-α and IL-1β mRNA expression in the brain of mice. JPEN J Parenter Enteral Nutr 2001;25:317-322.
20. Plata-Salaman CR, Ilyin SE, Gayle D. Brain cytokine mRNAs in anorectic rats bearing prostate adenocarcinoma tumor cells. Am J Physiol 1998;275:R566-R573.
21. Turrin NP, Ilyin SE, Gayle DA, et al. Interleukin-1β system in anorectic catabolic tumor-bearing rats. Curr Opin Clin Nutr Metab Care 2004;7:419-426.